Login / Signup

Desensitization in patients with hypersensitivity to platinum and taxane in gynecological cancers.

Tibor Andrea ZwimpferKathrin Scherer HofmeierAndreas SchötzauViola A Heinzelmann-SchwarzKarin HartmannMarcus VetterCéline Montavon Sartorius
Published in: Cancer medicine (2023)
Thus, we show that desensitization for platinum and taxane HSRs is safe and effective, resulting in an outcome that is well comparable to patients without HSR. Based on these observations, desensitization procedures might be considered as standard of care before switching to less effective treatment for patients with GC.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • healthcare
  • palliative care
  • peritoneal dialysis
  • chronic pain
  • affordable care act
  • patient reported